Team:Minnesota/Project
From 2013.igem.org
(Difference between revisions)
Line 150: | Line 150: | ||
<a href="https://2013.igem.org/Team:Minnesota/Project/Caffeine_Yeast"> | <a href="https://2013.igem.org/Team:Minnesota/Project/Caffeine_Yeast"> | ||
- | <img style="position:absolute; top: | + | <img style="position:absolute; top:125px;left:0px" id="MainCaffeineButton" src="http://drive.google.com/uc?export=view&id=0B1ulBujqO16-MktCSWQyN3BrdFU"> |
</a> | </a> | ||
<a href="https://2013.igem.org/Team:Minnesota/Project/Caffeine_Yeast"> | <a href="https://2013.igem.org/Team:Minnesota/Project/Caffeine_Yeast"> | ||
- | <img style="position:absolute; top: | + | <img style="position:absolute; top:125px;left:0px; display:none;" id="MainCaffeineButton2" src="http://drive.google.com/uc?export=view&id=0B1ulBujqO16-X0FxNzZXQUdEeDA"> |
</a> | </a> | ||
<a href="https://2013.igem.org/Team:Minnesota/Project/UV_Absorption"> | <a href="https://2013.igem.org/Team:Minnesota/Project/UV_Absorption"> | ||
- | <img style="position:absolute; top: | + | <img style="position:absolute; top:125px;left:325px" id="MainSunscreenButton" src="http://drive.google.com/uc?export=view&id=0B1ulBujqO16-T2doS0lKT2s1XzA"> |
</a> | </a> | ||
<a href="https://2013.igem.org/Team:Minnesota/Project/UV_Absorption"> | <a href="https://2013.igem.org/Team:Minnesota/Project/UV_Absorption"> | ||
- | <img style="position:absolute; top: | + | <img style="position:absolute; top:125px;left:325px; display:none;z-index:2;" id="MainSunscreenButton2" src="http://drive.google.com/uc?export=view&id=0B1ulBujqO16-TTNONGtDXzBDY28"> |
</a> | </a> | ||
Revision as of 20:14, 8 August 2013
Like us on FB and follow us on Twitter!
The 2013 University of Minnesota iGEM team aims to produce active human insulin by designing a versatile expression system in the industrially-relevant yeast, Pichia pastoris. The team will construct several novel expression systems and employ methanol-based induction systems using the standardized, modular design of the BioBricks systems. As well as this, the team will use cross-kingdom conjugation to advance the genetic toolkit available for transformation and expression in Pichia. Ultimately, we will utilize our system to produce active insulin as a proof-of-concept.